PL3286210T3 - Receptor komórek t - Google Patents

Receptor komórek t

Info

Publication number
PL3286210T3
PL3286210T3 PL16718859.8T PL16718859T PL3286210T3 PL 3286210 T3 PL3286210 T3 PL 3286210T3 PL 16718859 T PL16718859 T PL 16718859T PL 3286210 T3 PL3286210 T3 PL 3286210T3
Authority
PL
Poland
Prior art keywords
cell receptor
receptor
cell
Prior art date
Application number
PL16718859.8T
Other languages
English (en)
Inventor
Hans Stauss
Sharyn THOMAS
Ben WILLCOX
Fiyaz MOHAMMED
Original Assignee
Ucl Business Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucl Business Ltd filed Critical Ucl Business Ltd
Publication of PL3286210T3 publication Critical patent/PL3286210T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL16718859.8T 2015-04-20 2016-04-20 Receptor komórek t PL3286210T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1506642.6A GB201506642D0 (en) 2015-04-20 2015-04-20 T cell receptor
PCT/GB2016/051084 WO2016170320A1 (en) 2015-04-20 2016-04-20 T cell receptor

Publications (1)

Publication Number Publication Date
PL3286210T3 true PL3286210T3 (pl) 2024-02-19

Family

ID=53298826

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16718859.8T PL3286210T3 (pl) 2015-04-20 2016-04-20 Receptor komórek t

Country Status (12)

Country Link
US (2) US20180251513A1 (pl)
EP (1) EP3286210B1 (pl)
JP (2) JP7125264B2 (pl)
KR (1) KR20170137118A (pl)
CN (1) CN108055847A (pl)
AU (1) AU2016251395B2 (pl)
CA (1) CA2982702A1 (pl)
ES (1) ES2959587T3 (pl)
GB (1) GB201506642D0 (pl)
PL (1) PL3286210T3 (pl)
SG (1) SG11201708313QA (pl)
WO (1) WO2016170320A1 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3420000A1 (en) 2016-02-25 2019-01-02 Cell Medica Switzerland AG Modified cells for immunotherapy
GB201617714D0 (en) 2016-10-19 2016-11-30 Ucl Business Plc T Cell receptor
GB201617716D0 (en) * 2016-10-19 2016-11-30 Ucl Business Plc Cell
EP3441461A1 (en) 2017-08-11 2019-02-13 Baylor College of Medicine Cd1d-restricted nkt cells as a platform for off-the-shelf cancer immunotherapy
CN113573729A (zh) 2019-01-10 2021-10-29 詹森生物科技公司 前列腺新抗原及其用途
MX2021012054A (es) * 2019-04-11 2022-01-18 Fate Therapeutics Inc Reconstitución de cd3 en ipsc y células efectoras inmunitarias modificadas.
DE102019121007A1 (de) 2019-08-02 2021-02-04 Immatics Biotechnologies Gmbh Antigenbindende Proteine, die spezifisch an MAGE-A binden
GB201911286D0 (en) 2019-08-07 2019-09-18 Ucl Business Plc Method
TW202144389A (zh) 2020-02-14 2021-12-01 美商健生生物科技公司 在多發性骨髓瘤中表現之新抗原及其用途
TW202144388A (zh) 2020-02-14 2021-12-01 美商健生生物科技公司 在卵巢癌中表現之新抗原及其用途
TW202309071A (zh) 2021-05-05 2023-03-01 德商英麥提克生物技術股份有限公司 特異性結合ｐｒａｍｅ之抗原結合蛋白

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE417065T1 (de) * 2004-05-19 2008-12-15 Medigene Ltd Hochaffiner ny-eso-t-zellen-rezeptor
GB0911566D0 (en) 2009-07-03 2009-08-12 Immunocore Ltd T cell receptors
EA201390011A1 (ru) * 2010-07-28 2013-07-30 Иммьюнокор Лтд. Т-клеточные рецепторы
US9717758B2 (en) * 2013-05-17 2017-08-01 University Of Massachusetts High-affinity DMF5 T cell receptor (TCR) variants
CA2916960C (en) 2013-06-26 2022-12-06 Guangzhou Xiangxue Pharmaceutical Co. Ltd High-stability t-cell receptor and preparation method and application thereof
GB201617714D0 (en) * 2016-10-19 2016-11-30 Ucl Business Plc T Cell receptor

Also Published As

Publication number Publication date
CN108055847A (zh) 2018-05-18
CA2982702A1 (en) 2016-10-27
EP3286210A1 (en) 2018-02-28
JP7125264B2 (ja) 2022-08-24
US20210395331A1 (en) 2021-12-23
AU2016251395B2 (en) 2020-09-10
GB201506642D0 (en) 2015-06-03
ES2959587T3 (es) 2024-02-27
WO2016170320A1 (en) 2016-10-27
AU2016251395A1 (en) 2017-11-02
EP3286210B1 (en) 2023-10-18
JP2018512867A (ja) 2018-05-24
KR20170137118A (ko) 2017-12-12
SG11201708313QA (en) 2017-11-29
EP3286210C0 (en) 2023-10-18
US20180251513A1 (en) 2018-09-06
JP2021104051A (ja) 2021-07-26

Similar Documents

Publication Publication Date Title
IL262144A (en) t cell receptors
IL262128A (en) t cell receptors
IL262124A (en) t cell receptors
IL262146A (en) t cell receptors
IL264425B1 (en) t cell receptors against kras-g20
HK1252163A1 (zh) 受體
IL251524A0 (en) t cell receptors
GB201522592D0 (en) T cell receptors
HK1253694A1 (zh) T細胞受體文庫
GB201514875D0 (en) Receptor
SG11201708313QA (en) T cell receptor
PL3529267T3 (pl) Receptor komórek t
PL3433270T3 (pl) Receptory limfocytów t
GB201518991D0 (en) T cell receptors